Filter
1771
Filtered Results: 1771
Text search:
Diagnostics
and
Laboratory
Technology
Featured
Recommendations
185
New Publications
481
Language
Document type
No document type
909
Studies & Reports
317
Guidelines
282
Strategic & Response Plan
109
Manuals
108
Fact sheets
18
Training Material
11
Situation Updates
9
Brochures
2
Infographics
2
Online Courses
2
App
1
Resource Platforms
1
Countries / Regions
India
107
Global
70
Kenya
64
South Africa
47
Ethiopia
40
Nigeria
39
Liberia
38
Sierra Leone
35
Uganda
34
Tanzania
31
Western and Central Europe
30
Africa
29
Zambia
29
Rwanda
28
Latin America and the Carribbean
27
Nepal
24
Ghana
22
Namibia
20
Malawi
19
Bangladesh
17
Ukraine
16
South–East Asia Region
16
Philippines
15
Eastern Europe
14
Zimbabwe
13
Guinea
12
Asia
11
Botswana
11
Myanmar / Burma
11
Syria
10
Colombia
9
Lesotho
9
Cambodia
9
Congo, Democratic Republic of
9
West and Central Africa
9
East and Southern Africa
9
Senegal
8
Haiti
7
Argentina
7
Indonesia
7
Cameroon
6
Burkina Faso
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Eswatini/ Swaziland
6
Mozambique
5
USA
5
Brazil
5
Russia
5
Chile
4
Peru
4
Western Pacific Region
4
Bolivia
4
Tajikistan
3
Timor Leste/ East Timor
3
El Salvador
3
Afghanistan
3
North America
3
Vietnam
3
Sri Lanka
3
Iraq
3
Ecuador
3
North Macedonia
2
Thailand
2
Benin
2
China
2
Albania
2
Laos
2
Burundi
2
Bulgaria
2
Venezuela
2
Jordan
2
Germany
2
Paraguay
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Papua New Guinea
2
Georgia
2
Central African Republic
2
Pakistan
2
Gambia
1
Togo
1
Iran
1
Niger
1
Qatar
1
Dominican Republic
1
Hungary
1
Saudi Arabia
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Japan
1
France
1
United Kingdom
1
Moldova
1
Sudan
1
Yemen
1
Romania
1
Slovakia
1
Poland
1
Mali
1
Bhutan
1
South Sudan
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
714
Clinical Guidelines
183
Public Health
97
Key Resources
70
Pharmacy & Technologies
68
Women & Child Health
55
Capacity Building
16
Toolboxes
TB
211
COVID-19
139
AMR
121
HIV
116
Rapid Response
85
NTDs
79
Ebola & Marburg
48
Pharmacy
48
Caregiver
38
Planetary Health
31
Mental Health
30
Malaria
30
NCDs
28
Conflict
28
Zika
17
Health Financing Toolbox
16
Specific Hazards
14
Refugee
12
Global Health Education
11
Polio
9
Natural Hazards
8
Disability
8
Cholera
6
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti...
The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware and software packages listed in the following specifications are described in...
The National Guidelines for HIV-1 Viral Load Laboratory Testing support plans to scale up viral load (VL) testing to reach the 90-90-90 targets in India. This phased scale-up includes the setup of 70 additional VL testing laboratories nationally. These guidelines include laboratory design considerat...
Under-diagnosis of asthma in ‘under-fives’ may be alleviated by improved inquiry into disease history. We assessed a questionnaire-based screening tool for asthma among 614 ‘under-fives’ with severe respiratory illness in Uganda. The questionnaire responses were compared to post hoc consensu...
Despite the development of point-of-care diagnostic tests for syphilis, chlamydia, gonorrhoea, and trichomoniasis, none comply with all WHO criteria. This analysis overviews landscape analyses of point-of-care diagnostic technologies for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vagi...
User GuideThe toolkit is composed of three sections: Hospital and Health System Resources - includes a readiness assessment tool, the starting point in developing or enhancing a successful Antimicrobial Stewardship Program (ASP). The tool, a checklist developed by the CDC, should be shared with se...
The Manual for Parasitological Surveillance in Prevention of Reintroduction or Re-establishment of Malaria in Sri Lanka (2019) provides guidelines to health professionals on how to conduct effective malaria surveillance to prevent the reintroduction of the disease in Sri Lanka, which was certified m...
n October 2019, WHO convened the first meeting of the Buruli ulcer laboratory network (BU-LABNET) in Yaoundé, Cameroon, bringing together 11 laboratories from nine countries at the Pasteur Centre of Cameroon (CPC), the network’s Coordinating Centre. The network was formally established at th...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
Due to the anticipated significant rise in VL testing occasioned by Ghana’s adaptation of 2016 ART guidelines, it has become necessary to develop this VL scale-up and operational plan to assure complete client access to laboratory monitoring towards the achievement of the third 90 of the HIV care ...
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test for rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Leprosy Programme (NTLP) strategic plan and other nation...
The updated List of Essential Diagnostics contains 46 general tests that can be used for routine patient care as well as for the detection and diagnosis of a wide array of disease conditions, and 69 tests intended for the detection, diagnosis and monitoring of specific diseases.
The List is divid...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional considerations in the procurement of rapid tests.
